NCT03509207 2020-08-04
Vorinostat (SAHA) in Uterine Sarcoma
Medical University of Graz
Phase 2 Terminated
Clinical Trials
5 trialsNCT00918489 2018-10-17
SAHA-I
Heidelberg University
Phase 2 Completed
NCT00238303 2014-05-23
Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 2 Completed
NCT00641706 2014-05-14
Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
National Cancer Institute (NCI)
Phase 2 Completed
NCT00937495 2014-05-14
Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 2 Completed